NO176098C - Analogifremgangsmåte for fremstilling av 2-substituerte N,N'-ditrimetoksybenzoyl-piperaziner - Google Patents

Analogifremgangsmåte for fremstilling av 2-substituerte N,N'-ditrimetoksybenzoyl-piperaziner

Info

Publication number
NO176098C
NO176098C NO901631A NO901631A NO176098C NO 176098 C NO176098 C NO 176098C NO 901631 A NO901631 A NO 901631A NO 901631 A NO901631 A NO 901631A NO 176098 C NO176098 C NO 176098C
Authority
NO
Norway
Prior art keywords
ditrimethoxybenzoyl
piperazines
substituted
preparation
analogous process
Prior art date
Application number
NO901631A
Other languages
English (en)
Other versions
NO901631L (no
NO176098B (no
NO901631D0 (no
Inventor
Pierre Braquet
Eduardo Pirotzky
Jean-Jacques Godfroid
Francoise Heymans
Original Assignee
Sod Conseils Rech Applic
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Sod Conseils Rech Applic filed Critical Sod Conseils Rech Applic
Publication of NO901631D0 publication Critical patent/NO901631D0/no
Publication of NO901631L publication Critical patent/NO901631L/no
Publication of NO176098B publication Critical patent/NO176098B/no
Publication of NO176098C publication Critical patent/NO176098C/no

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D295/00—Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms
    • C07D295/16—Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms acylated on ring nitrogen atoms
    • C07D295/18—Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms acylated on ring nitrogen atoms by radicals derived from carboxylic acids, or sulfur or nitrogen analogues thereof
    • C07D295/182—Radicals derived from carboxylic acids
    • C07D295/192—Radicals derived from carboxylic acids from aromatic carboxylic acids
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/495—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with two or more nitrogen atoms as the only ring heteroatoms, e.g. piperazine or tetrazines
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00—Drugs for disorders of the respiratory system
    • A61P11/08—Bronchodilators
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A61P37/08—Antiallergic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P7/00—Drugs for disorders of the blood or the extracellular fluid
    • A61P7/02—Antithrombotic agents; Anticoagulants; Platelet aggregation inhibitors
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D241/00—Heterocyclic compounds containing 1,4-diazine or hydrogenated 1,4-diazine rings
    • C07D241/02—Heterocyclic compounds containing 1,4-diazine or hydrogenated 1,4-diazine rings not condensed with other rings
    • C07D241/04—Heterocyclic compounds containing 1,4-diazine or hydrogenated 1,4-diazine rings not condensed with other rings having no double bonds between ring members or between ring members and non-ring members
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D241/00—Heterocyclic compounds containing 1,4-diazine or hydrogenated 1,4-diazine rings
    • C07D241/02—Heterocyclic compounds containing 1,4-diazine or hydrogenated 1,4-diazine rings not condensed with other rings
    • C07D241/10—Heterocyclic compounds containing 1,4-diazine or hydrogenated 1,4-diazine rings not condensed with other rings having three double bonds between ring members or between ring members and non-ring members
    • C07D241/12—Heterocyclic compounds containing 1,4-diazine or hydrogenated 1,4-diazine rings not condensed with other rings having three double bonds between ring members or between ring members and non-ring members with only hydrogen atoms, hydrocarbon or substituted hydrocarbon radicals, directly attached to ring carbon atoms

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Medicinal Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Pulmonology (AREA)
  • Diabetes (AREA)
  • Hematology (AREA)
  • Immunology (AREA)
  • Epidemiology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
NO901631A 1989-04-15 1990-04-10 Analogifremgangsmåte for fremstilling av 2-substituerte N,N'-ditrimetoksybenzoyl-piperaziner NO176098C (no)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
GB898908587A GB8908587D0 (en) 1989-04-15 1989-04-15 New 2-substituted n,n'-ditrimethoxybenzoyl piperazines

Publications (4)

Publication Number Publication Date
NO901631D0 NO901631D0 (no) 1990-04-10
NO901631L NO901631L (no) 1990-10-16
NO176098B NO176098B (no) 1994-10-24
NO176098C true NO176098C (no) 1995-02-01

Family

ID=10655129

Family Applications (1)

Application Number Title Priority Date Filing Date
NO901631A NO176098C (no) 1989-04-15 1990-04-10 Analogifremgangsmåte for fremstilling av 2-substituerte N,N'-ditrimetoksybenzoyl-piperaziner

Country Status (32)

Country Link
US (1) US5019576A (no)
JP (1) JP2633709B2 (no)
KR (1) KR900016178A (no)
AR (1) AR247736A1 (no)
AT (1) AT399337B (no)
AU (1) AU631334B2 (no)
BE (1) BE1007245A3 (no)
CA (1) CA2014521C (no)
CH (1) CH681301A5 (no)
DE (1) DE4011925A1 (no)
DK (1) DK91890A (no)
DZ (1) DZ1407A1 (no)
ES (1) ES2019554A6 (no)
FI (1) FI92058C (no)
FR (2) FR2645743B1 (no)
GB (2) GB8908587D0 (no)
GR (1) GR1000355B (no)
HK (1) HK95092A (no)
IE (1) IE65058B1 (no)
IN (1) IN175799B (no)
IT (1) IT1241631B (no)
LU (1) LU87719A1 (no)
MA (1) MA21805A1 (no)
NL (1) NL9000798A (no)
NO (1) NO176098C (no)
NZ (1) NZ233250A (no)
OA (1) OA09446A (no)
PT (1) PT93736B (no)
SE (1) SE505186C2 (no)
SG (1) SG92092G (no)
TN (1) TNSN90051A1 (no)
ZA (1) ZA902566B (no)

Families Citing this family (10)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5344830A (en) * 1992-12-10 1994-09-06 Merck & Co., Inc. N,N-diacylpiperazine tachykinin antagonists
IL111730A (en) * 1993-11-29 1998-12-06 Fujisawa Pharmaceutical Co Piperazine derivatives, processes for their preparation and pharmaceutical preparations containing them
US5883098A (en) * 1993-11-29 1999-03-16 Fujisawa Pharmaceutical Co., Ltd. Piperazine derivatives
US5610165A (en) * 1994-02-17 1997-03-11 Merck & Co., Inc. N-acylpiperidine tachykinin antagonists
US5795894A (en) * 1995-05-02 1998-08-18 Schering Corporation Piperazino derivatives as neurokinn antagonists
CN1111528C (zh) * 1995-05-02 2003-06-18 先灵公司 用作神经激肽拮抗药的哌嗪衍生物
US5892039A (en) * 1995-08-31 1999-04-06 Schering Corporation Piperazino derivatives as neurokinin antagonists
BR9610277A (pt) * 1995-08-31 1999-07-06 Schering Corp Derivados de piperazino como antagonistas de neurowuinina
US5869488A (en) * 1996-05-01 1999-02-09 Schering Corporation Piperazino derivatives as neurokinin antagonists
FR2780649B1 (fr) * 1998-07-06 2001-03-09 Univ Paris Vii Denis Diderot Derives de la piperazine pour l'inhibition de la replication du virus de l'immunodeficience humaine

Family Cites Families (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB1243991A (en) * 1968-06-10 1971-08-25 Ici Ltd Piperidine, morpholine and piperazine derivatives
FR2209560A1 (en) * 1972-12-07 1974-07-05 Degussa N-(Trialkoxyaroyl)-ethylenediamine derivs - useful as cardioactive medicaments, exhibit anti-ischaemic activity comparable to nitroglycerin
IL85700A0 (en) * 1987-03-24 1988-08-31 Takeda Chemical Industries Ltd 1,4-disubstituted piperazine compounds,their production and use
EP0318235A3 (en) * 1987-11-25 1991-05-02 Takeda Chemical Industries, Ltd. Paf antagonist, 1,4-disubstituted piperazine compounds and production thereof
FI892468A (fi) * 1988-05-23 1989-11-24 Glaxo Group Ltd Piperazinderivat.
GB8823775D0 (en) * 1988-10-11 1988-11-16 Scras New 2-carbonyl substituted n n'-di-(trimethoxybenzoyl)piperazines
GB8823776D0 (en) * 1988-10-11 1988-11-16 Scras New 2-methoxycarbonyl sustituted n n'-di-(trimethoxybenzoyl)piperazines
US4997836A (en) * 1988-11-11 1991-03-05 Takeda Chemical Industries, Ltd. Trisubstituted piperazine compounds, their production and use

Also Published As

Publication number Publication date
IE901314L (en) 1990-10-15
FR2645743A1 (fr) 1990-10-19
SE505186C2 (sv) 1997-07-14
JP2633709B2 (ja) 1997-07-23
FI92058C (fi) 1994-09-26
ATA86690A (de) 1994-09-15
AT399337B (de) 1995-04-25
CA2014521C (en) 1997-09-09
ES2019554A6 (es) 1991-06-16
HK95092A (en) 1992-12-04
IE65058B1 (en) 1995-10-04
DK91890A (da) 1990-10-16
GR900100270A (en) 1991-09-27
FI92058B (fi) 1994-06-15
FI901883A0 (fi) 1990-04-12
NL9000798A (nl) 1990-11-01
GB9007612D0 (en) 1990-05-30
DE4011925A1 (de) 1990-10-18
FR2645859B1 (fr) 1992-06-05
IT1241631B (it) 1994-01-25
NO901631L (no) 1990-10-16
IT9020020A0 (it) 1990-04-12
FR2645743B1 (fr) 1992-06-05
FR2645859A1 (fr) 1990-10-19
SE9001269L (sv) 1990-10-16
AR247736A1 (es) 1995-03-31
CA2014521A1 (en) 1990-10-15
BE1007245A3 (fr) 1995-05-02
DK91890D0 (da) 1990-04-11
CH681301A5 (no) 1993-02-26
SE9001269D0 (sv) 1990-04-06
GB8908587D0 (en) 1989-06-01
KR900016178A (ko) 1990-11-12
PT93736B (pt) 1996-09-30
IN175799B (no) 1995-08-26
JPH02292266A (ja) 1990-12-03
GB2230262B (en) 1992-02-26
SG92092G (en) 1992-12-04
AU631334B2 (en) 1992-11-19
IT9020020A1 (it) 1991-10-12
PT93736A (pt) 1990-11-20
LU87719A1 (fr) 1990-07-24
GB2230262A (en) 1990-10-17
DZ1407A1 (fr) 2004-09-13
NZ233250A (en) 1991-03-26
GR1000355B (el) 1992-06-25
AU5326190A (en) 1990-11-01
TNSN90051A1 (fr) 1991-03-05
ZA902566B (en) 1991-01-30
NO176098B (no) 1994-10-24
MA21805A1 (fr) 1990-12-31
NO901631D0 (no) 1990-04-10
US5019576A (en) 1991-05-28
OA09446A (fr) 1992-10-15

Similar Documents

Publication Publication Date Title
NO179518C (no) AnalogifremgangsmÕte for fremstilling av 2- hydroksymetylcytosin-substituerte 1,3-oksatiolaner
FI890282A0 (fi) Menetelmä terapeuttisesti käyttökelpoisten 23,24-didehydro-25-hydroksikalsiferolijohdannaisten valmistamiseksi
FI891338A (fi) Parannus menetelmään 2',3'-dideoksi-2',3'-didehydronukleosidien valmistamiseksi
FI894546A (fi) Menetelmä uusien 2'-halogeenimetylideeni-, 2'-etenylideeni- ja 2'-etynyyliadenosiinijohdannaisten valmistamiseksi
NO176098C (no) Analogifremgangsmåte for fremstilling av 2-substituerte N,N'-ditrimetoksybenzoyl-piperaziner
FI895662A0 (fi) Menetelmä 3,4-difluorisubstituoidun benseenin valmistamiseksi
FR2630735B1 (fr) Procede de preparations d'halogenophenols
FI891111A (fi) Menetelmä 1,4-dihydropyridiinijohdannaisten valmistamiseksi
PT86623A (pt) Process for the preparation of derivatives of 3-aryl-5-alkylthio-4h-1,2,4-triazoles
FI943833A0 (fi) Menetelmä 2,3,5,6-tetraklooripyridiinin valmistamiseksi
NO179101C (no) Fremgangsmåte for fremstilling av dibeskyttet 2,3-hydroksymetyl-cyklobutanol
NO873353D0 (no) Fremgangsmaate for fremstilling av antibakterielle 7-okso-4-tia-1-azabicyklo(3.2.0)hept-2-en-derivater.
DK0377437T3 (da) Fremgangsmåde til fremstilling af 2,4-diamino-6-piperidinylpyrimidin-3-N-oxid
FI93363C (fi) Uusi menetelmä 2-diatso-3-trisubstituoitujen silyylioksi-3-butenoaattien valmistamiseksi
FR2666581B1 (fr) Procede de preparation d'acetate de tocopherol.
FI92393B (fi) Menetelmä 1,5-bentsotiatsepiinijohdannaisten valmistamiseksi
NO174196C (no) Fremgangsmåte for fremstilling av omega-decenol
FI102166B1 (fi) Menetelmä N,N-dimetyyliaminometyyliaryyliyhdisteiden valmistamiseksi
NO174554C (no) Fremgangsmåte til fremstilling av 1,2:3,5-di-O-iso-propyliden-
NO940861L (no) Fremgangsmåte for fremstilling av substituerte 2-aminoteraliner
NO180301C (no) Fremgangsmåte for fremstilling av azaspiroalkanderivater
NO177305C (no) Fremgangsmåte for fremstilling av 3-substituerte-2-oksindol-derivater
NO172286C (no) Framgangsmaate for framstilling av 1,5-benzotiazepinderivater
NO922254D0 (no) Framgangsmaate for framstilling av 1,5-benzotiazepinderivater
ES556220A0 (es) Procedimiento de preparacion de derivados de 1,4-dihidropiridinas